OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
26 hedge funds and large institutions have $2.71M invested in OncoSec Medical Incorporated in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
24% more funds holding
Funds holding: 21 → 26 (+5)
3% less capital invested
Capital invested by funds: $2.8M → $2.71M (-$97.1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$530K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$355K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$46K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$34.3K |
| 5 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$23.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$97.5K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$61K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$35.4K |
| 4 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$3.43K |
| 5 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
-$343 |
ONCS Hedge Fund Activity: Q4 2016 in Review
26 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q4 2016, worth a combined $2.71M — down 3.5% from $2.8M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ONCS positions and 2 closed out — a net gain of 6 holders — while 7 added to existing stakes and 3 trimmed.
The largest buyer was Sabby Management, adding an estimated $530K. The largest seller was Renaissance Technologies, cutting an estimated $97.5K.
- 26 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q4 2016, up from 21 in Q3 2016.
- Funds reported $2.71M of OncoSec Medical Incorporated stock for Q4 2016, down 3.5% quarter-over-quarter.
- 8 funds opened new OncoSec Medical Incorporated positions in Q4 2016 and 2 closed out, a net change of +6 holders.
- The largest OncoSec Medical Incorporated buyer in Q4 2016 was Sabby Management, an estimated $530K added.
- The largest OncoSec Medical Incorporated seller in Q4 2016 was Renaissance Technologies, an estimated $97.5K sold.
Based on aggregated 13F filings for Q4 2016.